September 12, 2023
New Bausch Health Treatment PrUCERIS® (budesonide) Aerosol Foam Now Available Across Canada to Treat Mild to Moderate Distal Ulcerative Colitis in Adults
September 11, 2023
Bausch Health’s Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
August 3, 2023
Bausch Health Announces Second-Quarter 2023 Results, other key updates from the Quarter, and raises Full-Year 2023 Revenue Outlook
No current content.